Product Code: ETC338490 | Publication Date: Aug 2022 | Updated Date: May 2024 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
Vietnam Pharmaceuticals market currently, in 2023, has witnessed an HHI of 660, Which has decreased slightly as compared to the HHI of 721 in 2017. The market is moving towards highly competitive. Herfindahl index measures the competitiveness of exporting countries. The range lies from 0 to 10000, where a lower index number represents a larger number of players or exporting countries in the market while a large index number means fewer numbers of players or countries exporting in the market.
The pharmaceuticals market in Vietnam has witnessed remarkable growth, driven by factors such as an aging population, increasing healthcare expenditure, and a growing prevalence of chronic diseases. The demand for both prescription and over-the-counter medications has surged, leading to a competitive pharmaceutical industry landscape. Local and multinational pharmaceutical companies operate in Vietnam, producing a wide range of drugs and medications to meet the healthcare needs of the population. Regulatory frameworks and quality standards have been strengthened to ensure the safety and efficacy of pharmaceutical products.
The Vietnam pharmaceuticals market is experiencing robust growth driven by multiple factors. The country`s expanding healthcare infrastructure and improving access to medical services are increasing the demand for pharmaceutical products. Furthermore, the growing prevalence of chronic diseases and the aging population create a continuous need for medications. In addition to domestic consumption, Vietnam is emerging as a pharmaceutical manufacturing hub for both domestic and export markets, attracting investments from global pharmaceutical companies. Regulatory reforms and the enforcement of quality standards are also enhancing the credibility of the Vietnamese pharmaceutical industry. As healthcare needs evolve and the pharmaceutical ecosystem develops, the Vietnam pharmaceuticals market is set to thrive.
The pharmaceuticals market in Vietnam faces challenges such as counterfeit drugs, price pressures, and access to healthcare. The prevalence of counterfeit medications can erode trust in the industry and endanger patient health. Additionally, government efforts to control drug prices can affect profitability for pharmaceutical companies, and ensuring affordable access to medicines remains a priority for the government and industry stakeholders.
The Vietnam pharmaceuticals market played a pivotal role in the country`s response to the COVID-19 pandemic. As healthcare systems faced unprecedented challenges, the demand for pharmaceuticals, including antiviral medications, surged. The government and healthcare authorities took proactive measures to ensure the availability and affordability of essential medicines. Local pharmaceutical companies also pivoted to meet the demand for critical drugs and medical supplies. The pandemic underscored the importance of a resilient and self-sufficient pharmaceutical industry. As the world transitions from crisis response to long-term preparedness, the Vietnam pharmaceuticals market is expected to continue evolving, with a focus on research and development, innovation, and healthcare infrastructure development.
The Vietnam pharmaceuticals market is characterized by several major players, including DHG Pharmaceutical Joint-Stock Company and Sanofi Vietnam. DHG Pharmaceutical is a leading domestic pharmaceutical company, producing a wide range of medications and contributing significantly to healthcare accessibility in Vietnam. Sanofi Vietnam, a subsidiary of the global pharmaceutical giant, has a strong presence in the country, offering a diverse portfolio of pharmaceutical products and therapeutic solutions. These companies have played a pivotal role in ensuring the availability of essential medications and driving advancements in healthcare in Vietnam.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Pharmaceuticals Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Pharmaceuticals Market Revenues & Volume, 2020 & 2030F |
3.3 Vietnam Pharmaceuticals Market - Industry Life Cycle |
3.4 Vietnam Pharmaceuticals Market - Porter's Five Forces |
3.5 Vietnam Pharmaceuticals Market Revenues & Volume Share, By Type, 2020 & 2030F |
3.6 Vietnam Pharmaceuticals Market Revenues & Volume Share, By Distribution Channel, 2020 & 2030F |
3.7 Vietnam Pharmaceuticals Market Revenues & Volume Share, By Route of Administration, 2020 & 2030F |
3.8 Vietnam Pharmaceuticals Market Revenues & Volume Share, By Drug Classification, 2020 & 2030F |
3.9 Vietnam Pharmaceuticals Market Revenues & Volume Share, By Mode of Purchase, 2020 & 2030F |
4 Vietnam Pharmaceuticals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Vietnam Pharmaceuticals Market Trends |
6 Vietnam Pharmaceuticals Market, By Types |
6.1 Vietnam Pharmaceuticals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Pharmaceuticals Market Revenues & Volume, By Type, 2020-2030F |
6.1.3 Vietnam Pharmaceuticals Market Revenues & Volume, By Pharmaceutical Drugs, 2020-2030F |
6.1.4 Vietnam Pharmaceuticals Market Revenues & Volume, By Biologics, 2020-2030F |
6.2 Vietnam Pharmaceuticals Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Pharmaceuticals Market Revenues & Volume, By Hospital Pharmacies, 2020-2030F |
6.2.3 Vietnam Pharmaceuticals Market Revenues & Volume, By Retail Pharmacies/ Drug Stores, 2020-2030F |
6.2.4 Vietnam Pharmaceuticals Market Revenues & Volume, By Others, 2020-2030F |
6.3 Vietnam Pharmaceuticals Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Pharmaceuticals Market Revenues & Volume, By Oral, 2020-2030F |
6.3.3 Vietnam Pharmaceuticals Market Revenues & Volume, By Parenteral, 2020-2030F |
6.3.4 Vietnam Pharmaceuticals Market Revenues & Volume, By Others, 2020-2030F |
6.4 Vietnam Pharmaceuticals Market, By Drug Classification |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Pharmaceuticals Market Revenues & Volume, By Branded Drugs, 2020-2030F |
6.4.3 Vietnam Pharmaceuticals Market Revenues & Volume, By Generic Drugs, 2020-2030F |
6.5 Vietnam Pharmaceuticals Market, By Mode of Purchase |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Pharmaceuticals Market Revenues & Volume, By Prescription-Based Drugs, 2020-2030F |
6.5.3 Vietnam Pharmaceuticals Market Revenues & Volume, By Over-The-Counter Drugs, 2020-2030F |
7 Vietnam Pharmaceuticals Market Import-Export Trade Statistics |
7.1 Vietnam Pharmaceuticals Market Export to Major Countries |
7.2 Vietnam Pharmaceuticals Market Imports from Major Countries |
8 Vietnam Pharmaceuticals Market Key Performance Indicators |
9 Vietnam Pharmaceuticals Market - Opportunity Assessment |
9.1 Vietnam Pharmaceuticals Market Opportunity Assessment, By Type, 2020 & 2030F |
9.2 Vietnam Pharmaceuticals Market Opportunity Assessment, By Distribution Channel, 2020 & 2030F |
9.3 Vietnam Pharmaceuticals Market Opportunity Assessment, By Route of Administration, 2020 & 2030F |
9.4 Vietnam Pharmaceuticals Market Opportunity Assessment, By Drug Classification, 2020 & 2030F |
9.5 Vietnam Pharmaceuticals Market Opportunity Assessment, By Mode of Purchase, 2020 & 2030F |
10 Vietnam Pharmaceuticals Market - Competitive Landscape |
10.1 Vietnam Pharmaceuticals Market Revenue Share, By Companies, 2023 |
10.2 Vietnam Pharmaceuticals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |